James McMahon
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS Research and Interventions 30
- HIV/AIDS drug development and treatment 17
- SARS-CoV-2 and COVID-19 Research 6
- Virology 26
- HIV Research and Treatment 25
- Co-authors
- Sharon R. Lewin (31 shared papers)Julian Elliott (14 shared papers)Michael R. Jordan (7 shared papers)Silvia Bertagnolio (5 shared papers)Jillian S. Y. Lau (14 shared papers)T Pribýl (3 shared papers)Tsuyoshi Kashima (3 shared papers)Kathy Kampf (3 shared papers)
- Journals
- AIDS (10 papers)The Lancet HIV (6 papers)AIDS Research and Human Retroviruses (4 papers)Journal of the International AIDS Society (3 papers)PLoS ONE (3 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
James McMahon
88 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 132
- Virology 682
- Infectious Diseases 1.1k
- Developmental Neuroscience 90
- Immunology 306
- Emergency Medicine 121
Countries citing papers authored by James McMahon
This map shows the geographic impact of James McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McMahon more than expected).
Fields of papers citing papers by James McMahon
This network shows the impact of papers produced by James McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McMahon. The network helps show where James McMahon may publish in the future.
Co-authors
The 25 scholars most cited alongside James McMahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 182 | |
| 2 | 2015 | 182 | |
| 3 | 1993 | 161 | |
| 4 | 2011 | 120 | |
| 5 | 2022 | 117 | |
| 6 | 2015 | 116 | |
| 7 | 2013 | 103 | |
| 8 | 2015 | 87 | |
| 9 | 2018 | 86 | |
| 10 | FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. | 1992 | 86 |
| 11 | 1998 | 81 | |
| 12 | 2017 | 61 | |
| 13 | 2016 | 60 | |
| 14 | 2010 | 53 | |
| 15 | 1996 | 52 | |
| 16 | 2011 | 47 | |
| 17 | 2012 | 45 | |
| 18 | 2016 | 44 | |
| 19 | 2020 | 39 | |
| 20 | 1996 | 39 |
About James McMahon
James McMahon is a scholar working on Infectious Diseases, Virology, Epidemiology, Molecular Biology and Immunology, having authored 94 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (17 papers), Immune Cell Function and Interaction (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), HIV-related health complications and treatments (5 papers), HIV, Drug Use, Sexual Risk (4 papers) and Semiconductor materials and devices (3 papers). The work is most often cited by research in Virology (682 citations), Infectious Diseases (1.1k citations), Developmental Neuroscience (90 citations), Immunology (306 citations) and Emergency Medicine (121 citations). James McMahon has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Sharon R. Lewin, Julian Elliott, Michael R. Jordan, Silvia Bertagnolio, Jillian S. Y. Lau, T Pribýl, Tsuyoshi Kashima, Kathy Kampf, Celia W. Campagnoni and Vance Handley. Their work appears in journals such as AIDS, The Lancet HIV, AIDS Research and Human Retroviruses, Journal of the International AIDS Society and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.